Sporadic adrenal tumour
Typical setting: A single adrenal chromaffin clone develops without an identified germline variant.
Autonomous catecholamine synthesis and release produces receptor-mediated systemic effects.
Phaeochromocytoma module
Trace catecholamine-secreting chromaffin tumours through episodic vasoconstriction, tachycardia, metabolic stress, crisis, biochemical diagnosis, alpha blockade, and surgery.
Clinically reviewed by Mark · NMC-registered nurse
Aetiology
Different triggers converge on the condition's central pathological process.
Typical setting: A single adrenal chromaffin clone develops without an identified germline variant.
Autonomous catecholamine synthesis and release produces receptor-mediated systemic effects.
Typical setting: Activating RET variants predispose to adrenal tumours with medullary thyroid and parathyroid disease.
Bilateral or multifocal disease can occur, changing screening and operative planning.
Typical setting: Loss of oxygen-sensing tumour suppression promotes chromaffin neoplasia.
A noradrenergic biochemical pattern and associated renal, retinal, or CNS tumours may occur.
Typical setting: Succinate dehydrogenase dysfunction creates pseudohypoxic signalling.
Extra-adrenal, multifocal, head-and-neck, or metastatic tumours are particularly relevant.
Typical setting: Anaesthesia, tumour manipulation, glucocorticoids, sympathomimetics, or inappropriate beta blockade can trigger release.
Sudden receptor stimulation produces hypertensive or haemodynamic crisis.
Mechanism chain
Follow each link and use it to predict the next clinical consequence.
Chromaffin enzyme activity generates excessive vasoactive amines.
Spontaneous secretion or triggers deliver abrupt circulating peaks.
Keep exploring